Biotalys N.V. EBIT

The latest EBIT for BTLS.BR is $-15M as of June 2026. That compares with $-15M in the prior-year period — up 0.9% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Biotalys N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BTLS.BR's EBIT moved from $-15M to $-15M — a 0.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biotalys N.V.'s operating scale or balance-sheet position.

Against its sector companies, BTLS.BR currently prints $-15M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Biotalys N.V.'s growth, margins, and balance sheet.

A EBIT figure of $-15M for BTLS.BR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting BTLS.BR's EBIT ($-15M), review year-over-year change from $-15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.